Neuberg Diagnostics expands its presence in India

Media Release

Neuberg Diagnostics expands its presence in India

Read Time: 3 minutes

India’s fourth largest pathology player, Neuberg Diagnostics Private Limited inaugurated a new state of the art pathology lab in Khammam, Telangana.

Neuberg Diagnostics expands its presence

The commencement of operations of the new lab in Khammam, Telangana is another step of Neuberg Diagnostics’ towards expanding its domestic and international presence.

Neuberg Diagnostics expands its presence in India

Last year, it had entered eastern and northern states by setting up greenfield labs and is expecting to be a significant player in those markets in  this financial year. It had also set up a CLIA approved molecular and genomic lab in the USA, in FY 22 with COVID testing facilities. 

SH. Puvvada Ajay Kumar, Minister of Transport, Telangana Government and SH. Nama Nageshwar Rao, local MP, TRS Party, SH. Errabelli Dayakar Rao, Minister of panchayat Raj & Rural Development, Telangana. 

The new lab was inaugurated by SH. Puvvada Ajay Kumar, Minister of Transport, Telangana Government and SH. Nama Nageshwar Rao, local MP, TRS Party, SH. Errabelli Dayakar Rao, Minister of panchayat Raj & Rural Development, Telangana. 

The group had closed FY 21 with a gross revenue of INR 800 crore. As a part of the expansion plan in FY22, Neuberg will be launching 30 new labs and more than 500 collection centres in domestic and international markets.

It will also be putting up technology incubation centers in  USA and Europe to access the latest technologies and make developing countries ready for precision diagnostics in the evolving personalized medicine arena.

Mr. A Ganesan, Group Vice Chairman, Neuberg Diagnostics

Mr. A Ganesan, Group Vice Chairman, Neuberg Diagnostics said, “Apart from inorganic growth, we are also setting up greenfield labs and mobile COVID testing units in orderto increase the reach of quality testing in small towns in India.

In terms of international expansion, we are looking to expand rapidly in the USA and also planningto open diagnostics facilities in East Africa and in West Asia.

We will becommissioninga newstate of arttesting facility in Dubai which will act as a hub in West Asia.

We are also planning to have our presence in Sri Lanka, Nepal, Bangladesh, and Germany during this Financial year. “

MS. Aishwarya Vasudevan, Group Chief Operating Officer, Neuberg Diagnostics Private Limited

Speaking on the development, MS. Aishwarya Vasudevan, Group Chief Operating Officer, Neuberg Diagnostics Private Limited, said, “The 2nd wave of covid had a major impact on the Indian healthcare ecosystem. There is a demand for superior healthcare services, right from diagnosis to treatment, in Tier II & III cities…our efforts are directed towards filling this gap.

This new lab at Khammam is an important milestone in Neuberg’s vision to helm the battle against disease by making available most advanced diagnostics tests within the reach of the common man across the globe, with a relentless focus on quality, cutting-edge technology and uncompromising ethics.”

Currently, Neuberg Diagnostics has 109 labs in India and 15 labs overseas (USA, South Africa, and Dubai). With 14 approved labs for Covid testing in India, the group has the capacity to process more than 65000 tests per day. Additionally, the group is also doing COVID tests from 3 of its labs in South Africa and 1 in the USA.

About Neuberg Diagnostics

Neuberg DiagnosticsBest-in-class laboratories across India, USA, UAE & South Africa have united under the banner of Neuberg Diagnostics, to bring the latest technology and techniques within the reach of developing countries.

Utilizing their combined strengths, the Neuberg brings capabilities to perform over 6000 varieties of Pathological investigations and promotes Prevention & Early Diagnosis, Focused Wellness Programs and Structured Disease Management programs for rare diseases using the most advanced technologies assisted by Data science and AI tools.

Today, Neuberg Diagnostics is among the top diagnostics companies of Indian origin and the fastest growing healthcare start-up in India.

With 18 approved labs for Covid testing in India, USA and South Africa, the group has more than 65000 COVID testing capacity in India.

Some of the best Pathologists, Biochemists, Geneticists, Microbiologists and several other Clinical Lab Professionals from around the world are working closely, sharing knowledge and using the latest generation of diagnostics techniques to take accurate and timely diagnosis to the next level.

Currently the group has over 120 labs and over 1000 touch points across 4 countries. Our Indian Expansion plans include setting up a network of 500 collection centers across the country within the next 12 months.

Our overseas expansion plans include establishing a presence in East Africa, West Africa, Sri Lanka, Nepal, Bangladesh, USA and Germany.

Neuberg also provides Hospital Laboratory Management Services, Preventive Health Checks, Corporate Wellness, Home Health Services and Drive through Phlebotomy Services.

 

MEDIA RELEASE

Previous Post
Rentokil PCI Super Saver Campaign for Residential Customers
Next Post
Bharat Biotech Concluded Final Analysis for COVAXIN® Efficacy from Clinical Trials

Related Posts

5 1 vote
Article Rating
Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments
Menu
0
Would love your thoughts, please comment.x
()
x